In line with our results, a recent study detected OPG autoantibodies in 8.2% of patients with axial spondyloarthropathy or ankylosing spondylitis using an ELISA for OPG analysis (Hauser et al., 2017). This evidence concerns the gene TNFRSF11B and ankylosing spondylitis.